Notification of a Public Meeting of the President's Commission on Combating Drug Addiction and the Opioid Crisis (Commission), 46309-46310 [2017-21360]

Download as PDF Federal Register / Vol. 82, No. 191 / Wednesday, October 4, 2017 / Notices sradovich on DSK3GMQ082PROD with NOTICES When Stabilization Fund assessments were collected, they were accounted for as expenses to credit unions and income to the Stabilization Fund. As the performance of the Legacy Assets improved and the NCUA collected legal recoveries, the projected assessment range became negative for the first time in 2013, indicating projected assessment rebates and recoveries of depleted corporate capital. At no time did the NCUA guarantee that assessment rebates would be made.36 Rather, the Board noted that the assessment rebates were projections and subject to change. Therefore, credit unions should not have been relying on a possible refund for managing their financial condition.37 A few commenters stated the ‘‘proposed method for closing the [Stabilization Fund] does nothing to address the excessive $1B charged since its creation to the [Asset Management Estates] by the NCUA.’’ It is unclear what expenses these commenters are referring to. The losses related to the corporate credit unions are described on the NCUA’s Web site. They include, among others, losses on investment securities (Legacy Assets), as well as costs of funding other pre-liquidation obligations the corporate credit unions had incurred. Every effort was made to keep the costs of resolving the failed corporate credit unions as low as possible.38 However, the resolution of the corporate credit unions was necessary and allowed the NCUA and credit union community to contain the financial and operational impact of the crisis. In addition, without being conserved and liquidated, the corporate credit unions (1) would have been unable to extend operations for the time required to realize uncertain legal recoveries; and (2) would have been unable to recover the material amounts the Board was able to recover without the benefit of the Act’s extender statute. Funds now available for distribution to 36 The agency is under no legal obligation to distribute any funds to insured credit unions other than amounts above where the NCUA Board sets the normal operating level. In accordance with the Act, the Board can only set the normal operating level as high as 1.50 percent. 12 U.S.C. 1782(h)(4). 37 Credit unions must be able to operate under a business model that provides for positive earnings and the accumulation of net worth irrespective of potential one-time increases in income. By their nature, one-time payouts such as a distribution from the Insurance Fund, are unpredictable and non-recurring. Therefore, credit unions must be able to operate in a safe and sound manner through normal, routine operations. 38 NCUA has provided details of the liquidation expenses and costs associated with each asset management estate on its Web site. See NCUA’s Q4 2016 Costs and Assessments Q&A (response to question 15) and the Stabilization Fund’s financial statements for additional information. VerDate Sep<11>2014 20:18 Oct 03, 2017 Jkt 244001 credit unions are due principally to legal recoveries that enabled the asset management estates to repay some of the losses the Stabilization Fund incurred. The Board appreciates commenters that considered how closing the Stabilization Fund might affect the NCUA’s contingency funding. The Board reminds stakeholders that Public Law 111–22, Helping Families Save Their Homes Act of 2009, increased the NCUA’s borrowing authority with the U.S. Treasury to $6 billion. This borrowing authority is shared by both the Stabilization Fund and the Insurance Fund. With closure of the Stabilization Fund, the Insurance Fund will retain the $6 billion borrowing authority. The Central Liquidity Facility’s contingency funding ability is not altered by closure of the Stabilization Fund. The Board will address comments on its separate proposal to amend the Insurance Fund distribution method in 12 CFR 741.4 in a separate action. IV. Final Action After considering the comments received, the Board approves the following: 1. Closing the Stabilization Fund in 2017 and distributing its funds, property, and other assets and liabilities to the Insurance Fund on October 1, 2017.39 2. Setting the normal operating level of the Insurance Fund to 1.39 percent, effective September 28, 2017.40 3. Adopting the policy for setting the normal operating level, as outlined below. Policy for Setting the Normal Operating Level Periodically, the NCUA will review the equity needs of the Insurance Fund and provide this analysis to stakeholders. Board action is only necessary when this review suggests that a change in the normal operating level is warranted. Any change to the normal operating level of more than 1 basis point shall be made only after a 39 As noted in the July 2017 Notice, the Stabilization Fund will be audited as of September 30, 2017. The financial statements of the Insurance Fund will continue to be presented under standards promulgated by the Federal Accounting Standards Advisory Board and audited each calendar year. The post-closure financial statements and note disclosures for the Insurance Fund will continue to provide the same level of detail about the receivables from the corporate asset management estates and related fiduciary activities. 40 As explained in the July 2017 Notice, an equity ratio of 1.39 percent will allow the Insurance Fund to withstand a moderate recession without the equity ratio falling below 1.20 percent over a fiveyear period. PO 00000 Frm 00099 Fmt 4703 Sfmt 4703 46309 public announcement of the proposed adjustment and opportunity for comment. In soliciting comment, the NCUA will issue a public report, including data supporting the proposal. When setting the normal operating level, the Board will seek to satisfy the following objectives: • Retain public confidence in federal share insurance; • Prevent impairment of the one percent contributed capital deposit; and • Ensure the Insurance Fund can withstand a moderate recession without the equity ratio declining below 1.20 percent over a five-year period. By the National Credit Union Administration Board on September 28, 2017. Gerard S. Poliquin, Secretary of the Board. [FR Doc. 2017–21305 Filed 10–3–17; 8:45 am] BILLING CODE 7535–01–P EXECUTIVE OFFICE OF THE PRESIDENT Office of National Drug Control Policy Notification of a Public Meeting of the President’s Commission on Combating Drug Addiction and the Opioid Crisis (Commission) Office of National Drug Control Policy (ONDCP). ACTION: Notice of meeting. AGENCY: ONDCP announces the fourth meeting of the President’s Commission on Combating Drug Addiction and the Opioid Crisis to advance the Commission’s work on drug issues and the opioid crisis per Executive Order 13784. The meeting will consist of discussion regarding insurance issues related to the opioid epidemic. DATES: The Commission meeting will be held on Friday October 20, 2017 from 11:00 a.m. until approximately 1:00 p.m. (Eastern time). ADDRESSES: The meeting will be held at the Eisenhower Executive Office Building, Room 350, in the Executive Office of the President in Washington, DC. It will be open to the public through livestreaming on https:// www.whitehouse.gov/live. FOR FURTHER INFORMATION CONTACT: General information concerning the Commission and its meetings can be found on ONDCP’s Web site at https:// www.whitehouse.gov/ondcp/presidentscommission. Any member of the public who wishes to obtain information about the Commission or its meetings that is not already on ONDCP’s Web site or SUMMARY: E:\FR\FM\04OCN1.SGM 04OCN1 sradovich on DSK3GMQ082PROD with NOTICES 46310 Federal Register / Vol. 82, No. 191 / Wednesday, October 4, 2017 / Notices who wishes to submit written comments for the Commission’s consideration may contact Michael Passante, Designated Federal Officer (DFO) via email at commission@ondcp.eop.gov or telephone at (202) 395–6709. Please note that ONDCP may post such written comments publicly on our Web site, including names and contact information that are submitted. There will not be oral comments from the public at the meeting. Requests to accommodate disabilities with respect to livestreaming or otherwise should also be sent to that email address, preferably at least 10 days prior to the meeting to allow time for processing. SUPPLEMENTARY INFORMATION: The Commission was established in accordance with E.O. 13784 of March 29, 2017, the Commission’s charter, and the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. App. 2, to obtain advice and recommendations for the President regarding drug issues. The Executive Order, charter, and information on the Members of the Commission are available on ONDCP’s Web site. The Commission will function solely as an advisory body and will make recommendations regarding policies and practices for combating drug addiction with particular focus on the current opioid crisis in the United States. The date of the Commission’s final report has been extended until November 1, 2017. Per E.O. 13784, the Commission shall: a. Identify and describe the existing Federal funding used to combat drug addiction and the opioid crisis; b. assess the availability and accessibility of drug addiction treatment services and overdose reversal throughout the country and identify areas that are underserved; c. identify and report on best practices for addiction prevention, including healthcare provider education and evaluation of prescription practices, collaboration between State and Federal officials, and the use and effectiveness of State prescription drug monitoring programs; d. review the literature evaluating the effectiveness of educational messages for youth and adults with respect to prescription and illicit opioids; e. identify and evaluate existing Federal programs to prevent and treat drug addiction for their scope and effectiveness, and make recommendations for improving these programs; and; f. make recommendations to the President for improving the Federal response to drug addiction and the opioid crisis. VerDate Sep<11>2014 20:18 Oct 03, 2017 Jkt 244001 Dated: September 29, 2017. Michael Passante, Deputy General Counsel, Designated Federal Officer. [FR Doc. 2017–21360 Filed 10–3–17; 8:45 am] BILLING CODE 3280–F5–P NUCLEAR REGULATORY COMMISSION [NRC–2017–0199] Availability of Revised NRC Form 3, ‘‘Notice to Employees’’ email to pdr.resource@nrc.gov. The ADAMS accession number for each document referenced (if it is available in ADAMS) is provided the first time that it is mentioned in this document. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. FOR FURTHER INFORMATION CONTACT: Lisamarie L. Jarriel, Office of Enforcement, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001; telephone: 301–287–9006, email: Lisamarie.Jarriel@nrc.gov. SUPPLEMENTARY INFORMATION: Nuclear Regulatory Commission. ACTION: Generic communications; issuance. Background The U.S. Nuclear Regulatory Commission (NRC) is announcing the availability of the latest version of NRC Form 3, ‘‘Notice to Employees.’’ The NRC Form 3 describes certain responsibilities and rights of employers and employees who engage in NRCregulated activities. Licensees are required by law to post the form at prominent locations at the workplace to permit workers to view it easily. Additionally, the NRC is announcing that future revisions of Form 3 will be publicized through an alternative electronic means in addition to the Federal Register. DATES: The revised form is available as of October 4, 2017. ADDRESSES: Please refer to Docket ID NRC–2017–0199 when contacting the NRC about the availability of information regarding this document. You may obtain publicly-available information related to this document using any of the following methods: • Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC–2017–0199. Address questions about NRC dockets to Carol Gallagher; telephone: 301–415–3463; email: Carol.Gallagher@nrc.gov. For technical questions, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by The purpose of this notice is to inform all licensees that NRC Form 3, ‘‘Notice to Employees,’’ has been revised. The NRC Form 3 describes certain responsibilities and rights of employers and employees who engage in NRCregulated activities, including how employees can report violations or other safety concerns directly to the NRC. Section 19.11(e)(1) of title 10 of the Code of Federal Regulations (10 CFR), states that licensees shall prominently post the most recent version of NRC Form 3, ‘‘Notice to Employees’’ within 30 days of receiving the revised NRC Form 3 from the Commission. In a 1997 rulemaking, 10 CFR 19.11 was amended to incorporate a reference to the latest version of NRC Form 3. This eliminated the need to revise the CFR whenever NRC Form 3 is changed, which had been the previous practice. The final rule published on September 15, 1997 (62 FR 48165) indicated that the NRC would inform licensee of future changes to NRC Form 3 by an administrative letter and, in addition, the availability of any new versions would be noticed in the Federal Register. Administrative letters were a type of generic communication issued to inform addressees of specific regulatory or administrative information but were discontinued in September 1999. As such, in lieu of an administrative letter, this revision and future revisions will be publicized through an alternative electronic means (i.e. Web site notice, social networking service, etc.) to alert all licensees of the new revisions, as well as in the Federal Register. A new version of NRC Form 3 was issued in August 2017, to make a correction to the map of the NRC Regions and clarify operation of the Headquarters Operations Center. To view the current version of NRC Form 3 (8/2017), please go to https:// www.nrc.gov/reading-rm/doc- AGENCY: SUMMARY: PO 00000 Frm 00100 Fmt 4703 Sfmt 4703 E:\FR\FM\04OCN1.SGM 04OCN1

Agencies

[Federal Register Volume 82, Number 191 (Wednesday, October 4, 2017)]
[Notices]
[Pages 46309-46310]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-21360]


=======================================================================
-----------------------------------------------------------------------

EXECUTIVE OFFICE OF THE PRESIDENT

Office of National Drug Control Policy


Notification of a Public Meeting of the President's Commission on 
Combating Drug Addiction and the Opioid Crisis (Commission)

AGENCY: Office of National Drug Control Policy (ONDCP).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: ONDCP announces the fourth meeting of the President's 
Commission on Combating Drug Addiction and the Opioid Crisis to advance 
the Commission's work on drug issues and the opioid crisis per 
Executive Order 13784. The meeting will consist of discussion regarding 
insurance issues related to the opioid epidemic.

DATES: The Commission meeting will be held on Friday October 20, 2017 
from 11:00 a.m. until approximately 1:00 p.m. (Eastern time).

ADDRESSES: The meeting will be held at the Eisenhower Executive Office 
Building, Room 350, in the Executive Office of the President in 
Washington, DC. It will be open to the public through livestreaming on 
https://www.whitehouse.gov/live.

FOR FURTHER INFORMATION CONTACT: General information concerning the 
Commission and its meetings can be found on ONDCP's Web site at https://www.whitehouse.gov/ondcp/presidents-commission. Any member of the 
public who wishes to obtain information about the Commission or its 
meetings that is not already on ONDCP's Web site or

[[Page 46310]]

who wishes to submit written comments for the Commission's 
consideration may contact Michael Passante, Designated Federal Officer 
(DFO) via email at commission@ondcp.eop.gov or telephone at (202) 395-
6709. Please note that ONDCP may post such written comments publicly on 
our Web site, including names and contact information that are 
submitted. There will not be oral comments from the public at the 
meeting. Requests to accommodate disabilities with respect to 
livestreaming or otherwise should also be sent to that email address, 
preferably at least 10 days prior to the meeting to allow time for 
processing.

SUPPLEMENTARY INFORMATION: The Commission was established in accordance 
with E.O. 13784 of March 29, 2017, the Commission's charter, and the 
provisions of the Federal Advisory Committee Act (FACA), as amended, 5 
U.S.C. App. 2, to obtain advice and recommendations for the President 
regarding drug issues. The Executive Order, charter, and information on 
the Members of the Commission are available on ONDCP's Web site. The 
Commission will function solely as an advisory body and will make 
recommendations regarding policies and practices for combating drug 
addiction with particular focus on the current opioid crisis in the 
United States. The date of the Commission's final report has been 
extended until November 1, 2017. Per E.O. 13784, the Commission shall:
    a. Identify and describe the existing Federal funding used to 
combat drug addiction and the opioid crisis;
    b. assess the availability and accessibility of drug addiction 
treatment services and overdose reversal throughout the country and 
identify areas that are underserved;
    c. identify and report on best practices for addiction prevention, 
including healthcare provider education and evaluation of prescription 
practices, collaboration between State and Federal officials, and the 
use and effectiveness of State prescription drug monitoring programs;
    d. review the literature evaluating the effectiveness of 
educational messages for youth and adults with respect to prescription 
and illicit opioids;
    e. identify and evaluate existing Federal programs to prevent and 
treat drug addiction for their scope and effectiveness, and make 
recommendations for improving these programs; and;
    f. make recommendations to the President for improving the Federal 
response to drug addiction and the opioid crisis.

    Dated: September 29, 2017.
Michael Passante,
Deputy General Counsel, Designated Federal Officer.
[FR Doc. 2017-21360 Filed 10-3-17; 8:45 am]
 BILLING CODE 3280-F5-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.